Simvastatin (MK-733): Mechanism of Action

Simvastatin (MK-733) MOA：Targeting HMG-CoA Reductase/Mevalonate Pathway for Cancer Therapeutics

🎯 check Simvastatin (MK-733) product page

Simvastatin (MK-733) is a lipophilic HMGCR inhibitor. It affects RhoA signaling by blocking mevalonate, reducing cholesterol.

Primary Applications and Mechanism of Action

Jump to: